Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia

Duman, Neval; UYANIK, Abdullah; Unsal, Abdulkadir; Sezer, Siren; ÇAMSARI, TANER; Cirit, Mustafa; YILMAZ, MEHMET; ALTUN, BÜLENT; Duranay, Murat; Yildiz, Alaattin; ŞAHİN, İDRİS; DOĞUKAN, AYHAN; ÜSTÜNDAĞ, SEDAT; KARAYAYLALI, İBRAHİM; VELİOĞLU, ARZU; Sindel, Sukru; KIYKIM, AHMET; YENİÇERİOĞLU, YAVUZ; Akbas, Ertugrul; Ozdener, Fatih

doi:10.1093/ckj/sfu079

Once-monthly continuous erythropoietin receptor activator (CERA) for haemoglobin maintenance in haemodialysis patients with chronic renal anaemia

Copy For Citation

Duman N., UYANIK A., Unsal A., Sezer S., ÇAMSARI T., Cirit M., ...More

CLINICAL KIDNEY JOURNAL, vol.7, no.5, 2014 (ESCI)

Publication Type: Article / Article
Volume: 7 Issue: 5
Publication Date: 2014
Doi Number: 10.1093/ckj/sfu079
Journal Name: CLINICAL KIDNEY JOURNAL
Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus
Hacettepe University Affiliated: Yes

Abstract

Background. This study was conducted to evaluate the efficacy and safety of once-monthly continuous erythropoietin receptor activator (CERA) for maintenance of stable haemoglobin (Hb) levels in adult chronic renal anaemia patients on dialysis according to local clinical judgment in Turkey.